IM Cannabis Corp. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

INVENTORY

INVENTORY

12 Months Ended

Dec. 31, 2023

Classes of current inventories [abstract]

INVENTORY [Text Block]

NOTE 9:-

INVENTORY

	December 31, 2023
	Capitalized costs		Fair valuation adjustment, net		Carrying value
Work in progress:
Bulk cannabis	$	3,735	$	-	$	3,735
Finished goods:
Packaged dried cannabis		4,667		984		5,651
Other products		590		-		590

Balance as of December 31, 2023		8,992		984		9,976

	December 31, 2022
	Capitalized costs		Fair valuation adjustment, net		Carrying value
Work in progress:
Bulk cannabis	$	5,364	$	1,265	$	6,629
Finished goods:
Packaged dried cannabis		8,665		549		9,214
Other products		742		-		742

Balance as of December 31, 2022	$	14,771	$	1,814	$	16,585

During the years ended December 31, 2023, 2022 and 2021, inventory expensed to cost of revenue of cannabis products was $35,154, $63,517 and $43,720, respectively, which included $984, $4,342 and $8,796 of non-cash expense (out of which, a total of $nil, $2,528 and $226 attributable to the discontinued operations of the Canadian entities, see Note 25), respectively, related to the changes in fair value of inventory sold.

Cost of revenues in 2023, 2022 and 2021, also include production overhead not allocated to costs of inventory produced and recognized as an expense as incurred.